Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00412828
Status:
COMPLETED
Last Update Posted:
2015-02-19
First Post:
2006-12-18
Brief Title:
A Phase III Study of CR011-vcMMAE in Subjects With Unresectable Stage III or Stage IV Melanoma
Sponsor:
CuraGen Corporation
Organization:
Celldex Therapeutics
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-06
Start Date Type:
None
Primary Completion Date:
2010-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-05
Completion Date Type:
ACTUAL
First Submit Date:
2006-12-18
First Submit QC Date:
December 18 2006
Study First Post Date:
2006-12-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2015-02-02
Disp First Submit QC Date:
February 2 2015
Disp First Post Date:
2015-02-19
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2015-02-02
Last Update Post Date:
2015-02-19
Last Update Post Date Type:
ESTIMATED